Search

Layla D. Berry

Examiner (ID: 2498, Phone: (571)272-9572 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1609, 1693, 1623, 1673
Total Applications
1717
Issued Applications
1094
Pending Applications
107
Abandoned Applications
562

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19150124 [patent_doc_number] => 11975014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-07 [patent_title] => Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof [patent_app_type] => utility [patent_app_number] => 17/228342 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16786 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17228342 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/228342
Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof Apr 11, 2021 Issued
Array ( [id] => 18348706 [patent_doc_number] => 20230136817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-04 [patent_title] => TREATMENT OF ACUTE RESPIRATORY DISEASE SYNDROME (ARDS) WITH POLYSULFATED POLYSACCHARIDES [patent_app_type] => utility [patent_app_number] => 17/917904 [patent_app_country] => US [patent_app_date] => 2021-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10291 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917904 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/917904
Treatment of acute respiratory disease syndrome (ARDS) with polysulfated polysaccharides Apr 8, 2021 Issued
Array ( [id] => 17945731 [patent_doc_number] => 20220332748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => COMPOUNDS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS [patent_app_type] => utility [patent_app_number] => 17/222802 [patent_app_country] => US [patent_app_date] => 2021-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222802 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/222802
Compounds and methods for the treatment of ocular disorders Apr 4, 2021 Issued
Array ( [id] => 17297933 [patent_doc_number] => 20210393772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => ADJUVANT AND VACCINE COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 17/219154 [patent_app_country] => US [patent_app_date] => 2021-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219154 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/219154
ADJUVANT AND VACCINE COMPOSITIONS Mar 30, 2021 Abandoned
Array ( [id] => 19050852 [patent_doc_number] => 20240092821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => SYNTHESIS OF OLIGONUCLEOTIDES AND RELATED COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/916064 [patent_app_country] => US [patent_app_date] => 2021-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916064 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/916064
SYNTHESIS OF OLIGONUCLEOTIDES AND RELATED COMPOUNDS Mar 29, 2021 Pending
Array ( [id] => 16962969 [patent_doc_number] => 20210214468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => METHOD FOR MANUFACTURING A SHAPED CROSS-LINKED HYALURONIC ACID PRODUCT [patent_app_type] => utility [patent_app_number] => 17/216084 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216084 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/216084
Method for manufacturing a shaped cross-linked hyaluronic acid product Mar 28, 2021 Issued
Array ( [id] => 18071410 [patent_doc_number] => 11530233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-20 [patent_title] => Beta-nicotinate ester nucleotides and processes for preparing same [patent_app_type] => utility [patent_app_number] => 17/216533 [patent_app_country] => US [patent_app_date] => 2021-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 29 [patent_no_of_words] => 13089 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17216533 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/216533
Beta-nicotinate ester nucleotides and processes for preparing same Mar 28, 2021 Issued
Array ( [id] => 18725787 [patent_doc_number] => 20230340004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-26 [patent_title] => PREPARATION METHOD FOR HIGH-PURITY GRANATIN A [patent_app_type] => utility [patent_app_number] => 17/925613 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19795 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2614 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925613 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/925613
Preparation method for high-purity granatin A Mar 23, 2021 Issued
Array ( [id] => 17512562 [patent_doc_number] => 11291679 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-04-05 [patent_title] => Injectable, infusable, instillable ivermectin adjuvant for cancer therapies [patent_app_type] => utility [patent_app_number] => 17/208012 [patent_app_country] => US [patent_app_date] => 2021-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3052 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17208012 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/208012
Injectable, infusable, instillable ivermectin adjuvant for cancer therapies Mar 21, 2021 Issued
Array ( [id] => 17928466 [patent_doc_number] => 20220323591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-13 [patent_title] => HEPARIN NANO DRUG CARRIER SYSTEM LOADED WITH AMINO ANTI-TUMOR DRUG AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/634447 [patent_app_country] => US [patent_app_date] => 2021-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6043 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634447 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/634447
HEPARIN NANO DRUG CARRIER SYSTEM LOADED WITH AMINO ANTI-TUMOR DRUG AND PREPARATION METHOD THEREOF Mar 20, 2021 Abandoned
Array ( [id] => 17119656 [patent_doc_number] => 11130778 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-28 [patent_title] => CD73 inhibitors [patent_app_type] => utility [patent_app_number] => 17/204272 [patent_app_country] => US [patent_app_date] => 2021-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27697 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204272 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/204272
CD73 inhibitors Mar 16, 2021 Issued
Array ( [id] => 18274622 [patent_doc_number] => 11613553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-28 [patent_title] => Methods of preparing 1'-cyano nucleosides [patent_app_type] => utility [patent_app_number] => 17/198829 [patent_app_country] => US [patent_app_date] => 2021-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22065 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198829 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/198829
Methods of preparing 1'-cyano nucleosides Mar 10, 2021 Issued
Array ( [id] => 18338384 [patent_doc_number] => 20230130333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS [patent_app_type] => utility [patent_app_number] => 17/908176 [patent_app_country] => US [patent_app_date] => 2021-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908176 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/908176
METHOD FOR MANUFACTURING PHOSPHONATE ESTERS AND METHOD FOR MANUFACTURING PHOSPHATE ESTERS Mar 2, 2021 Pending
Array ( [id] => 19050894 [patent_doc_number] => 20240092863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => ANTIMICROBIAL TARGET [patent_app_type] => utility [patent_app_number] => 17/909318 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8631 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17909318 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/909318
ANTIMICROBIAL TARGET Mar 1, 2021 Pending
Array ( [id] => 17080574 [patent_doc_number] => 20210275580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => IRON CARBOHYDRATE COMPLEX FOR TREATMENT OF RESTLESS LEG SYNDROME (RLS) [patent_app_type] => utility [patent_app_number] => 17/182366 [patent_app_country] => US [patent_app_date] => 2021-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8824 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182366 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/182366
Iron carbohydrate complex for treatment of restless leg syndrome (RLS) Feb 22, 2021 Issued
Array ( [id] => 17967040 [patent_doc_number] => 11484545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-01 [patent_title] => Compounds and methods for treating neurological and cardiovascular conditions [patent_app_type] => utility [patent_app_number] => 17/180469 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 30062 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180469 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/180469
Compounds and methods for treating neurological and cardiovascular conditions Feb 18, 2021 Issued
Array ( [id] => 18328272 [patent_doc_number] => 11633489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-25 [patent_title] => Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant [patent_app_type] => utility [patent_app_number] => 17/178430 [patent_app_country] => US [patent_app_date] => 2021-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 7105 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178430 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/178430
Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant Feb 17, 2021 Issued
Array ( [id] => 18334778 [patent_doc_number] => 20230126726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => CROSSLINKED HYALURONIC ACID AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/905871 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7490 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905871 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/905871
CROSSLINKED HYALURONIC ACID AND USE THEREOF Feb 16, 2021 Pending
Array ( [id] => 16900740 [patent_doc_number] => 20210179656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF [patent_app_type] => utility [patent_app_number] => 17/178151 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77145 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 1004 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178151 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/178151
SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Feb 16, 2021 Abandoned
Array ( [id] => 16868465 [patent_doc_number] => 20210161932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST [patent_app_type] => utility [patent_app_number] => 17/176383 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7269 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176383 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176383
TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST Feb 15, 2021 Abandoned
Menu